Results for tag: "Troxacitabine"

Troxacitabine is an oncology drug used to treat certain types of cancer. It is a nucleoside analog, which means it works by interfering with the growth of cancer cells. It is used to treat acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). It is also used in combination with other drugs to treat certain types of lymphoma. Troxacitabine is administered intravenously and is usually given in cycles of three weeks on and one week off. Common side effects include nausea, vomiting, diarrhea, fatigue, and fever. The Troxacitabine market is a rapidly growing segment of the oncology drug market. It is used to treat a variety of cancers, and its efficacy and safety profile make it an attractive option for many patients. The market is expected to continue to grow as more patients are diagnosed with cancer and as new treatments become available. Some companies in the Troxacitabine market include AstraZeneca, Novartis, Pfizer, and Merck. Show Less Read more